[Intravenous fluconazole use in the treatment of fungic endogenous endophthalmitis: case report].
The authors describe a case of endogenous Candida albicans endophthalmitis in one extremely low birth-weight newborn refractory to endovenous amphotericin B treatment that presented resolution with the use of endovenous fluconazole. Clinical aspects of endogenous Candida albicans endophthalmitis are also pointed out by a review of the literature.
Dotto
Patrícia de Freitas
Pde F
Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP.
Rodrigues
Luciana Duarte
LD
Fernandes
Maria de Lourdes Brandão
Mde L
Figueira
Bettina Barbosa Duque
BB
Takahashi
Walter Yukihiko
WY
Carani
José Carlos Eudes
JC
Serracarbassa
Pedro Durães
PD
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy*; D009877:Endophthalmitis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007275:Injections, Intravenous; D008297:Male; D014463:Ultrasonography
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole